Gene expression profiling of the human natural killer cell response to Fc receptor activation: unique enhancement in the presence of interleukin-12 by Amanda R. Campbell et al.
RESEARCH ARTICLE Open Access
Gene expression profiling of the human
natural killer cell response to Fc receptor
activation: unique enhancement in the
presence of interleukin-12
Amanda R. Campbell1,2†, Kelly Regan2,3†, Neela Bhave1, Arka Pattanayak3, Robin Parihar4, Andrew R. Stiff1,2,
Prashant Trikha1, Steven D. Scoville1,2, Sandya Liyanarachchi5, Sri Vidya Kondadasula6, Omkar Lele3,
Ramana Davuluri7, Philip R. O. Payne3 and William E. Carson III1,8,9*
Abstract
Background: Traditionally, the CD56dimCD16+ subset of Natural Killer (NK) cells has been thought to mediate
cellular cytotoxicity with modest cytokine secretion capacity. However, studies have suggested that this subset may
exert a more diverse array of immunological functions. There exists a lack of well-developed functional models to
describe the behavior of activated NK cells, and the interactions between signaling pathways that facilitate effector
functions are not well understood. In the present study, a combination of genome-wide microarray analyses and
systems-level bioinformatics approaches were utilized to elucidate the transcriptional landscape of NK cells
activated via interactions with antibody-coated targets in the presence of interleukin-12 (IL-12).
Methods: We conducted differential gene expression analysis of CD56dimCD16+ NK cells following FcR stimulation
in the presence or absence of IL-12. Next, we functionally characterized gene sets according to patterns of gene
expression and validated representative genes using RT-PCR. IPA was utilized for biological pathway analysis, and an
enriched network of interacting genes was generated using GeneMANIA. Furthermore, PAJEK and the HITS algorithm
were employed to identify important genes in the network according to betweeness centrality, hub, and authority
node metrics.
Results: Analyses revealed that CD56dimCD16+ NK cells co-stimulated via the Fc receptor (FcR) and IL-12R led to the
expression of a unique set of genes, including genes encoding cytotoxicity receptors, apoptotic proteins, intracellular
signaling molecules, and cytokines that may mediate enhanced cytotoxicity and interactions with other immune cells
within inflammatory tissues. Network analyses identified a novel set of connected key players, BATF, IRF4, TBX21, and
IFNG, within an integrated network composed of differentially expressed genes in NK cells stimulated by various
conditions (immobilized IgG, IL-12, or the combination of IgG and IL-12).
Conclusions: These results are the first to address the global mechanisms by which NK cells mediate their biological
functions when encountering antibody-coated targets within inflammatory sites. Moreover, this study has identified a
set of high-priority targets for subsequent investigation into strategies to combat cancer by enhancing the anti-tumor
activity of CD56dimCD16+ NK cells.
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Background
Natural killer (NK) cells are large granular lymphocytes
that participate in the innate immune response to virally
infected and malignant cells. NK cells possess a diverse
repertoire of natural killer cell receptors (NKRs) that
allow NK cells to recognize MHClow or MHCnegative tar-
get cells or non-classical MHC molecules (e.g. MICA/B
and ULBP). The physiological functions of NK cells are
regulated by a delicate balance of signals transmitted via
activating and inhibitory NKRs [1]. NK cells interact
with antibody (Ab)-coated target cells via the FcγRIIIa
or CD16, an activating, low-affinity receptor for the Fc
portion of IgG [2]. Further, our group has demonstrated
in vitro and in vivo that co-stimulation of NK cells with
stimulatory cytokines such as interleukin (IL)-12 signifi-
cantly enhances the immune response to Ab-coated
tumor cells [3]. NK cells are uniquely equipped to medi-
ate such Ab-dependent effector functions because they
contain abundant cytolytic granules, prominently express
cellular adhesion molecules, constitutively express mul-
tiple cytokine receptors, and rapidly secrete immune mod-
ulatory cytokines following activation. These properties
provide NK cells with the ability to directly lyse cellular
targets as well as coordinate the developing adaptive im-
mune response.
Human peripheral blood NK cells may be divided
into two subsets based on their cell surface density of
CD56 and CD16 molecules. The majority of NK cells
(approximately 90 %) are phenotypically characterized
as CD56dimCD16+, while the remaining cells are
CD56brightCD16neg [4]. The CD56brightCD16neg NK cell
population is thought to be the immediate precursor to
the CD56dimCD16+ subset and plays an important role
in regulating immune responses via cytokine-mediated
cross-talk with T cells and dendritic cells (DCs) [5–7].
In contrast, the cytotoxic CD56dimCD16+ NK cell sub-
set expresses higher levels of chemokine receptors, and
therefore is preferentially recruited to peripheral sites
of inflammation [8]. Within inflammatory environ-
ments, encounters between CD56dimCD16+ NK cells
and target cells as well as exposure to locally secreted
inflammatory cytokines promotes activation of this sub-
set, leading to dramatically increased cytotoxic activity
against target cells and abundant pro-inflammatory
cytokine production equivalent to that of the
CD56brightCD16neg population [9–11]. The early re-
cruitment and activation of CD56dimCD16+ NK cells to
sites of inflammation raises important questions re-
garding the potential immune functions of these cells
that extend beyond their cytotoxic capabilities. Thus,
the present study has sought to elucidate the complex
genomic profile of activated CD56dimCD16+ NK cells
via a series of laboratory and bioinformatics-based
approaches.
The systems-level bioinformatics-based approaches
employed in this study build upon the results of our
laboratory-based studies, augmented with publicly avail-
able data sets and knowledge collections. Specifically, we
have applied network-based analysis methods to gene
expression data derived from microarray analyses. In
such analyses, individual biomolecular entities (e.g.,
genes, gene products, bio-chemical agents, etc.) belong
to a larger system, with specific structural or functional
relationships serving to “link” together the entities com-
prising that system. In these systems, the biomolecular
entities may be referred to as “vertices” and the relation-
ships that connect those vertices may be referred to as
“edges” [12]. These relationships are identified via ca-
nonical information retrieval workflows. Such workflows
are designed for inspection of multiple sources of rele-
vant data; including but not limited to biomedical litera-
ture, public data sets, and collections of knowledge
structured in formalized constructs known as ontologies.
A simplified and illustrative example of this type of
network-level systems analysis approach is provided in
Fig. 1. Once a network construct is generated, it may be
used to identify critical vertices that, if targeted in a
diagnostic or therapeutic context, have a maximal ability
to influence the function of the overall biological system
in question. Indeed, it has been described that such
network-based approaches may enhance the ability to
identify “high yield” targets for diagnostics or therapeu-
tics, thus optimizing the selection and pursuit of action-
able and clinically relevant hypotheses [13]. To our
knowledge, this is the first network analysis approach
used to identify a set of high-priority gene targets based
on transcriptome profiling of NK cells under unique
stimulation conditions.
In this study, we present a novel application of a sys-
tems biology approach to evaluate the global patterns
of gene expression in CD56dimCD16+ NK cells follow-
ing FcR stimulation in the presence or absence of the
potent immune-stimulatory cytokine, IL-12. Oligonucleo-
tide microarrays and Real-Time PCR were utilized to elu-
cidate expression patterns of various genes in activated
NK cells. Bioinformatics-based approaches were employed
to build upon our observations and inform future investi-
gation regarding the role of activated CD56dimCD16+ NK
cells. Further, the immunologic and bioinformatics-based
analyses of NK cell function in response to clinically
relevant co-stimuli presented herein may be useful for
the evaluation of experimental immunologic results in
future studies. Importantly, the transcriptional profiles
described in this manuscript provide insight regarding
the potential functions of this NK cell subset during in-
teractions with Ab-coated targets in the context of host
defense as well as in the setting of monoclonal antibody
therapy for cancer.
Campbell et al. BMC Medical Genomics  (2015) 8:66 Page 2 of 17
Methods
Cytokines and antibodies
Recombinant human IL-12 (rhuIL-12) was provided by
Genetics Institute, Inc. (Cambridge, MA). Anti-FcγRIIIa
antibody 3 g8 was obtained from Medarex Inc. (Annandale,
NJ). Polyclonal human IgG (huIgG) was purchased from
Sigma-Aldrich Co. (St. Louis, MO).
Isolation of human NK cells
NK cells were isolated directly from fresh peripheral
blood Leukopaks (American Red Cross, Columbus, OH)
by 30-min incubation with RossetteSep cocktail (Stem
Cell Technologies, Vancouver, BC), followed by ficoll
hypaque density gradient centrifugation. NK cells were >
95 % CD56+ by FACS analysis. The CD56dimCD16+ hu-
man NK cell population was isolated via FACS sorting
(BD FACSAria IIu) of cells stained with CD56-PE (Beck-
man Coulter, Pasadena, CA) and CD16-FITC, Clone
VEP13 (Miltenyi Biotec, Bergisch Gladbach, Germany)
antibodies, yielding a population that was > 98 % pure.
Human NK cells were cultured in RPMI-1640 medium
supplemented with 10 % heat-inactivated pooled human
AB serum (HAB) (C-six Diagnostics; Germantown, WI),
100 units/mL of penicillin, 100 μg/mL of streptomycin,
and 0.25 μg/mL of amphotericin B (10 % HAB medium).
In vitro co-stimulation assays
For NK cell FcR activation by immobilized IgG, wells of
a 96-well flat-bottom plate were coated with 100 μg/mL
of polyclonal huIgG in cold PBS overnight at 4 °C. Plates
then were washed, and human NK cells were plated at 2
x 105 cells/well with IL-12, as previously described [9].
For NK cell FcR activation by FcγRIIIa clustering, hu-
man NK cell FcγRIIIa were cross-linked with F(ab’)2
fragments of monoclonal Ab (mAb) 3 g8 and goat
F(ab’)2 anti-mouse Ig secondary Ab, in the presence of
10 ng/mL huIL-12. For FcR activation by NK cell co-
culture with Ab-coated tumor cells, wells of a 96-well
flat-bottom culture plate were coated with the HER2-
overexpressing cell line SK-BR-3. 5 x 104 tumor cells
were grown to confluence overnight at 37 °C. The cul-
ture supernatant was aspirated the following day, wells
were treated with 100 μg/mL trastuzumab (Herceptin™,
an anti-HER2 mAb) for 1 h at 37 °C and then washed
twice with warm medium to remove any unbound Ab.
Purified NK cells were added at 2 x 105 cells/well in the
presence of 10 ng/mL rhuIL-12, as previously described
[9]. Control wells contained tumor plus NK cells supple-
mented with medium alone, trastuzumab alone, or
rhuIL-12 alone. Following activation, cell-free culture su-
pernatants were harvested at the indicated time-points
and analyzed for levels of human cytokines (IFN-γ, TNF-
α, and MIP1-α) by ELISA (Endogen, Inc, Rockford, IL).
Statistical analysis of ELISA cytokine levels was per-
formed using the Student’s paired t-test, with p < 0.05
considered significant.
Preparation of labeled RNA and microarray hybridization
Total cellular RNA from NK cells obtained from individ-
ual donors (n = 8) was isolated and subjected to a cleanup
protocol with RNeasy mini kits (Qiagen, Valencia, CA),
according to the manufacturer’s specifications. The quality
of total RNA was assessed using an Agilent Bioanalyzer.
First and second strand cDNA was prepared from 8 μg of
total RNA, and the cDNA was subjected to in vitro tran-
scription in the presence of biotinylated nucleoside tri-
phosphates. The biotinylated cRNA was fragmented to
uniform sizes and the integrity of the labeled cRNA was
verified by gel electrophoresis. Affymetrix GeneChip ex-
pression array U133A was hybridized with each prepared
Fig. 1 Overview of the network-level systems analysis approach. This type of methodology utilizes a combination of observed data, public data sets,
the mining of applicable domain literature, and/or ontologies (e.g., expertly curated collections of domain knowledge represented in a computable
format). In this example, vertices (e.g., genes, gene products, and biological structures or functions) are linked together by edges that represent relevant
biological relationships
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cRNA target in duplicate, according to the manufacturer’s
instructions. The raw and processed microarray data is
made publicly available in GEO (GSE63038).
Gene microarray data analysis
The DNA-Chip Analyzer (dChip) software package
implementing model-based expression analysis of oligo-
nucleotide arrays was used to obtain gene expression
estimates for the samples in the study. The scanned
microarray images were normalized using the invariant
set scaling method at the probe level, and then model-
based gene expression estimates using the Perfect
Match (PM) Only Model were obtained using dChip
software. When examining the reproducibility of normal-
ized duplicates for each of the eight NK donors, significant
correlation was observed between each donor duplicate
(average r2 > 0.992, not shown).
The study was performed using a “2 x 2 factorial”
complete block design with two factors, at two levels, to
understand the effect of each single simulation as well as
the combined simulation, considering blocking factors
as “subjects” [14]. All eight subjects were treated with
four treatment combinations; no stimulation (medium),
FcR stimulation by immobilized IgG, IL-12 stimulation,
and combined stimulation via FcR plus IL-12. An analysis
of variance test was performed for the block-treatment
model with the assumption that there was no interaction
between blocks and treatments for each gene. Then, pairs
of treatment combinations were compared by using cell
mean comparison contrasts. Since six treatment compari-
son contrasts were performed for each gene, Bonferroni
correction was applied to correct for multiple compari-
sons. In each comparison, gene expression values were
considered to be significantly different between two treat-
ment combinations if the p-value < 0.008, the median of
fold changes of eight subjects was greater than 2 and the
median of absolute differences in gene intensity of eight
subjects was greater than 150. Hierarchical clustering ana-
lysis was performed using the heatmap.2 function as part
of the “gplots” R package [15, 16].
Three paired comparisons were made between genes
regulated in NK cells following each activation condi-
tion: 1) FcR activation by immobilized IgG vs. no stimu-
lation (medium), 2) IL-12 vs. medium, and 3) FcR
activation in the presence of IL-12 vs. medium. Venn di-
agrams were constructed by intersecting the set of genes
up- or down-regulated by 2-fold or greater in each of
the three comparisons. These diagrams were evaluated
by Subject Matter Experts (SMEs) to assess the relative
importance and/or impact of such up- or down-regulated
genes in intersecting sets. Functional annotation (Gene
Ontology) was performed for the up-regulated and down-
regulated genes in each of the three comparisons using
Database for Annotation, Visualization and Integrated
Discovery (DAVID) software [17].
Real-time PCR
The expression values of select genes identified via the
microarray experiments were validated by Real-Time PCR.
Following RNeasy purification of NK cell lysates from the
immobilized IgG assay, 2 μg of total RNA was reverse
transcribed and the resulting cDNA was used as a tem-
plate to measure gene expression by Real-Time PCR using
pre-designed primer/probe sets (Assays On Demand;
Applied Biosystems, Foster City, CA) according to the
manufacturer’s recommendations, as previously described
[18]. Human β-actin (Applied Biosystems) was used as the
internal control in each reaction well. Real-Time PCR data
was analyzed using the ABI PRISM® 7900 Sequence Detec-
tion System.
Network driven functional enrichment analysis
Generating an integrated network consisting of an enriched
set of functionally significant genes
An integrated network of biomolecular features aggre-
gated from pathway knowledge bases was created to form
inductive hypotheses regarding the contribution of each
differentially expressed gene in this NK cell activation
study [19]. We focused our analysis on three sets of genes
that were found to exhibit two-fold or greater differential
expression (p < 0.008) when NK cells were activated in the
presence of only immobilized IgG (FcR stimulus), only IL-
12 (IL-12R stimulus), or both IgG and IL-12. The most
common biomolecular functions identified amongst the
enriched set of genes were then used as filtering criteria to
aggregate additional genes with the same or similar cellu-
lar, molecular, or biological functionality. This measure-
ment of functional enrichment indicates the proportion of
genes demonstrating a specific biological function within
a broader collection of genes, and serves as the basis of
functional enrichment analysis workflows [20]. The result-
ing enriched gene sets were used to prioritize genes that
are influenced upon by NK-cell activation in the presence
of IL-12 and immobilized IgG. The free and open-source
gene function prediction service, GeneMANIA [21], was
used along with the widely used large-scale network
visualization and integration tool, Cytoscape [22] to
formulate and visualize the resultant integrated gene
network.
Using Network-centric Measures to Identify Top Genes
Within the Integrated Network
Once the enriched, integrated network was constructed,
the next step was to identify genes that may not have been
recovered by differential gene expression analysis, but
might in fact be biologically interesting by virtue of func-
tional relationships between top genes in the integrated
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network, regardless of whether they were identified ex-
perimentally or via computational methods. One primary
criterion used for the identification of the aforementioned
genes was a high degree of Betweenness Centrality (BC)
relative to the rest of the integrated network [23]. BC is
quantified for a particular vertex as the number of shortest
paths between pairs of other vertices in the network that
pass through this vertex [24]. PAJEK, a software package
for manipulation and analysis of large-scale networks, was
used to calculate the BC scores [25]. Additionally, the
Hyperlink-Induced Topic Search (HITS) algorithm [26]
was used to measure two important characteristics of an
overall genomic network, including directed linkages,
namely: 1) the authority of individual genes, and 2) the
hub value of individual genes. A hub vertex is quantified
via summing the authority vertices that it is directed to,
and an authority vertex is quantified via summing the hub
vertices that are directed towards it. The HITS algorithm
searches for dense links between sets of highly ranked
hubs pointing to sets of highly ranked authorities.
Discovering the highest represented signaling pathways
with the ingenuity pathway analysis toolkit
To complement the purely structural analysis of gene
function networks, we subsequently conducted bio-
logical pathway analysis. In order to determine the top
pathways represented among the genes in the integrated
network described previously, the pathway analysis and
visualization toolkit, Ingenuity Pathway Analysis (IPA),
was used. IPA scores networks in a manner that prob-
abilistically demonstrates that genes in the supplied data
set are functionally relevant to their constituent net-
works. The toolkit identified several pathways that were
highly relevant to the supplied gene set. The top two
canonical pathways, as reported by IPA, were selected
for further inspection.
Results
IL-12 enhances NK cell activation in response to
immobilized IgG
The aim of this study was to determine the gene expres-
sion profile of human CD56dimCD16+ NK cells following
FcR activation in a pro-inflammatory environment, such
as that which would occur in the presence of a cytokine
like IL-12 (formerly known as NK cell stimulatory fac-
tor). Previous studies examining NK cell FcR activation
have utilized NK cells cultured with low-dose IL-2 or
irradiated feeder cells for maintenance of NK cell viability
[27–29]. In order to ensure that the gene expression data
in this study were derived from an NK cell population that
had been activated through the FcR alone, we utilized an
immobilized IgG assay previously established in our la-
boratory [9]. We have demonstrated that IL-12 signal
transduction enhances the NK cell cytokine response to
FcR activation in vitro, in murine models, and in phase I
clinical trials [30–32]. Importantly, previous work also has
shown that IL-12 is superior to IL-2, IL-15, IL-18, and IL-
21 in triggering cytokine secretion by FcR-stimulated NK
cells [33]. We therefore examined NK cell cytokine pro-
duction in response to immobilized IgG in the presence
or absence of IL-12 as a means of confirming the effective-
ness of this stimulation strategy. Purified NK cells that
were cultured for 72 h in the presence of immobilized IgG
and IL-12 produced large amounts of interferon-gamma
(IFN-γ), while NK cells stimulated with immobilized IgG
alone or IL-12 alone produced only moderate amounts
of IFN-γ. This pattern of cytokine production was simi-
lar to that produced following NK cell activation by dir-
ect FcR cross-linking or by co-culture of NK cells with
trastuzumab-coated HER2/neu positive human breast
cancer cells (Fig. 2a). While maximal accumulation of
IFN-γ, MIP1-α, and TNF-α occurred after 72 h in cul-
ture, cytokine production could be detected within 6 h
(Fig. 2b-d). Real-Time RT-PCR revealed a 20-fold
increase in cytokine transcript within NK cells co-
stimulated with immobilized IgG and IL-12 after 8 h in
culture, with optimal transcript induction occurring at
12 h (Fig. 2e). These data confirmed that immobilized
IgG represents a physiologically-relevant NK cell stimu-
lus and indicated that this model would be adequate for
assessment of global gene expression in a primary hu-
man CD56dimCD16+ NK cell population following FcR
activation in the presence or absence of IL-12.
Microarray analysis of NK cells stimulated via the FcR in
the presence of IL-12
In order to begin to investigate the gene expression
profiles of human CD56dimCD16+ NK cells following
co-stimulation via engagement of the FcR and IL-12R,
CD56dimCD16+ NK cells derived from eight healthy do-
nors were purified and sorted by flow cytometry, plated
separately in the four conditions of the immobilized
IgG assay (medium, immobilized IgG, IL-12, or IgG
plus IL-12) for 12 h, then harvested for RNA prepar-
ation. cRNA samples from each donor were prepared.
Gene expression profiling was performed by individu-
ally hybridizing the cRNA samples to the Affymetrix
GeneChip expression array U133A, which interrogates
14,500 human genes.
A list of differentially expressed genes among the four
stimulation conditions was compiled. Initially, four sets of
gene expression intensity values were generated for each
NK cell donor: resting NK cells (medium), immobilized
IgG-stimulated NK cells, IL-12-stimulated NK cells, and
IgG plus IL-12 co-stimulated NK cells, and next, bioinfor-
matics analyses were performed to examine the most
highly represented structural and functional relationships
between differentially genes (Fig. 3a). The gene expression
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patterns for the four stimulation conditions were orga-
nized by a hierarchical clustering algorithm of variable
genes that exhibited a 2-fold or greater change in expres-
sion. Mean levels were calculated for each gene across all
samples. The magnitude of expression of a particular gene
relative to the calculated mean expression was reflected by
use of color representation. The resultant gene expression
profiles are presented in heatmap format with correspond-
ing dendrograms for samples and genes (Fig. 3b). The
organization and length of the branches in the dendro-
gram reflect the similarity in gene expression profiles
between each of the NK cell stimulation conditions.
The distance between the branch lengths (on the hori-
zontal axis) reflects the comparative difference in gene
expression profiles between each sample. Hierarchical
clustering across all samples using differentially
expressed genes across any of the three comparisons
showed that the four main sub-groups were correctly
Fig. 2 NK cells secrete high levels of immune stimulatory cytokines following FcR activation in the presence of IL-12. a Human NK cells were
stimulated via their FcR by culture onto wells pre-coated with either huIgG or Ab-coated SK-BR-3 tumor cells, or by direct FcR cross-linking by
3 g8 Ab. IL-12 was added at a concentration of 10 ng/mL. Control wells consisted of NK cells cultured with medium alone (medium), FcR
activation alone (via immobilized huIgG, Ab-coated tumor, or 3 g8 cross-linking, as indicated), or IL-12 alone (IL-12). Culture supernatants were
harvested after 12 h and analyzed for IFN-γ content by ELISA. In time-course experiments, NK cells were cultured onto immobilized huIgG with
IL-12 for varying times (4-72 h) and supernatants were analyzed for (b) IFN-γ, (c) MIP-1α, and (d) TNF-α. The means and SEM are shown with n = 3 for
each experiment. *p < 0.001 vs. Medium, FcR activation alone, and IL-12 alone. e NK cells cultured in the immobilized IgG plus IL-12 condition were
harvested at varying times and processed for Real-Time PCR analysis of IFN-γ transcript. Results are given as fold increase in cytokine transcript over
baseline (Medium). The means and SEM are shown (n = 3). *p < 0.01 vs. Medium, immobilized IgG, and IL-12. Similar results were observed for gene
expression of MIP-1α and TNF-α (not shown)
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classified into the corresponding four NK cell stimulation
conditions with only 3 misclassifications (IL-12 sample 7,
IL-12 sample 6 and IgG-IL-12 sample 6). Importantly, NK
cells stimulated via the FcR (in the presence or absence of
IL-12) exhibited gene expression patterns that were sig-
nificantly different from that observed following stimula-
tion with media or IL-12 alone. These initial observations
suggested that the gene expression profile of immobilized
IgG plus IL-12 stimulated NK cells was distinct from that
of single-condition stimulated cells and provided the
rationale to further investigate the expression profile of
co-stimulated NK cells.
In order to confirm the quality of these experimental
results, these data were evaluated and correlated with
existing gene expression data from the literature. The
gene expression levels of bonafide NK cell activation
Fig. 3 FcR activation in the presence of IL-12 results in differential expression of a unique subset of genes. a Human NK cells were isolated from
peripheral blood and cultured with immobilized IgG, IL-12, or IgG and IL-12. Following stimulation, culture supernatants were harvested and levels
of cytokines were analyzed by ELISA. Genomewide expression profiling was performed for NK cells derived from all 8 samples via microarray, and
representative transcript expression levels were validated using Real-time RT-PCR. The bioinformatics portion of this study utilized a set of genes
that exhibited the greatest expression level differences as reported by microarray. Functional enrichment analysis generated an integrated network of
structural interactions among differentially expressed genes. Canonical pathway interactions were mapped using IPA. Select genes within top enriched
GO functional categories were validated using Real-time RT-PCR (dotted line). b Hierarchical clustering based on the expression profile of genes that
were up- or down-regulated by at least 2-fold across all samples. Each row represents relative hybridization intensities of a particular gene across
different samples. Colors reflect the magnitude of relative expression of a particular gene across samples. Brighter green corresponds to higher
expression and brighter red corresponds to lower expression. The organization and length of the branches in the resulting dendrogram reflect
the similarity in gene expression profiles between each of the samples. The division and length of the branches within the dendrogram reflect
the relative similarity in gene expression profiles between each NK cell stimulation condition. The terminal branches that are close spatially in
the dendrogram represent the NK cell conditions that have the most similar gene expression patterns. Venn diagrams generated by the intersection of
the list of genes (c) up-regulated or (d) down-regulated by at least 2-fold vs. stimulation with medium alone are shown
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markers were found to be up-regulated upon co-
stimulation of NK cells via immobilized IgG and IL-12.
For example, as seen in previous reports, gene expres-
sion levels of IFN-γ and granzyme B were found to be up-
regulated in response to FcR and IL-12R co-stimulation.
[29, 34]. Several other genes that were up-regulated upon
activation include CKS2, CCND2, CXCL10, and IL-4R
[29, 35]. The NK cell receptors 2B4 and KLRF1 were
down-regulated when NK cells were co-stimulated via
immobilized IgG and IL-12, which also is consistent
with previously published reports [36, 37]. (See Additional
file 1 for the full list of differentially regulated genes.)
Analysis of gene expression data was initiated by per-
forming the following comparisons: 1) immobilized IgG
stimulated NK cells vs. unstimulated NK cells (medium),
2) IL-12 stimulated NK cells vs. medium, and 3) IgG plus
IL-12 co-stimulated NK cells vs. medium. Genes that were
differentially expressed 2-fold or greater under the stimu-
lation conditions were included in the comparisons. Add-
itional file 1 lists genes and their change in expression
calculated from these three comparisons. The total num-
ber of genes up- or down-regulated by each stimulation
condition were arranged into Venn diagrams in order to
globally assess those genes that were modulated across
multiple stimulation conditions and those genes that were
uniquely up- or down-regulated by a specific stimulus
(Fig. 3c-d). The gene expression profile of immobilized
IgG-stimulated NK cells revealed that there were 151
genes that were significantly up-regulated by > 2-fold (14
of those genes were up-regulated uniquely by this stimu-
lus), while only 56 genes were down-regulated > 2-fold (5
down-regulated uniquely). IL-12 stimulation led to a sub-
stantial up-regulation of 19 genes (3 unique to this stimu-
lus) while no genes were significantly down-regulated.
IFNG (also referred to as IFN-γ) was found to be up-
regulated 10-fold, which is consistent with previous re-
ports describing IL-12 mediated NK cell activation [38].
Finally, 241 genes were up-regulated in response to immo-
bilized IgG plus IL-12 co-stimulation (97 uniquely), and
215 genes were down-regulated (164 uniquely). Of note,
only 4 up-regulated genes overlapped among the three
comparison groups, while the majority of up-regulated
genes, 133/151 and 16/19, uniquely overlapped between
IgG and IgG + IL-12 and IL-12 and IgG + IL-12, respect-
ively. Similarly, the majority of down-regulated genes in
the IgG stimulation condition (51/56) was also recovered
in the IgG + IL-12 condition. Taken together, these data
suggest that NK cells co-stimulated via the FcR and IL-
12R express a genetic profile that is unique, synergistic,
and non-additive.
Gene ontology classification of microarray data
Next, up-regulated and down-regulated genes were cat-
egorized based on their functional characteristics from
available gene ontology (GO) annotations in public da-
tabases (Additional file 2a-b). Additional file 3 contains
a complete list of the individual genes within each
functional category. Genes that were significantly up-
regulated in response to immobilized IgG and the com-
bination of IgG plus IL-12 revealed that the following
functional categories were over-represented in this list
of genes relative to all annotated genes on the array: re-
sponse to biotic stimuli, chemotaxis, NK cell mediated
cytotoxicity, and promoters of apoptosis. The only GO
term significantly represented by the IL-12 condition
was JAK-STAT signaling, which is the predominant
cytokine-associated cell-signaling pathway [39]. Similarly,
statistical analyses of the genes that were down-regulated
showed that the following functional categories were over-
represented in IgG plus IL-12 NK cells: cell membrane-
linked signal transduction, cell adhesion, response to
biotic stimuli, cell cycle control, phosphorylation, and
apoptosis.
Genes uniquely regulated in NK cells following FcR
activation in the presence of IL-12
Given that the dual stimulation condition might best
represent how NK cells respond upon encountering
antibody-coated targets within an inflammatory envir-
onment, we subsequently examined those genes that
were uniquely regulated by FcR activation in the pres-
ence of IL-12. The expression profile of the 97 uniquely
up-regulated and 164 uniquely down-regulated genes in
co-stimulated NK cells was analyzed by functional
annotation of GO terms (DAVID). Functional categor-
ies and their constituent genes are depicted in Fig. 4a-e.
Within the apoptosis category, genes encoding endogen-
ous pro-apoptotic molecules such as ASC (apoptosis-asso-
ciated speck-like protein containing a CARD), BNIP3L
(BCL2/adenovirus E1B 19 kDa interacting protein 3-like),
STK17A (serine/threonine kinase 17a apoptosis inducing)
and CIDEB (cell death-inducing DFFA-like effector b)
were all negatively regulated. This suggests enhanced pro-
survival signaling within the co-stimulated NK cells as
compared to those cells activated by a single stimulus.
Also, consistent with the known cytotoxic capabilities of
activated CD56dimCD16+ NK cells, our analysis revealed
several genes encoding secreted or cell-surface cytolytic
molecules in the apoptosis grouping that were uniquely
up-regulated in co-stimulated NK cells; e.g., granzyme B,
cytochrome c, and multiple TNF superfamily ligands
(Fig. 4a). In the cytokines and growth factors category,
CXCR4 (chemokine [C-X-C motif] receptor 4), IL10RA
(interleukin 10 receptor alpha), CX3CR1 (chemokine [C-
X3-C motif] receptor 1) and IL11RA (interleukin 11 re-
ceptor alpha) were down-regulated 3–5 fold (Fig. 4b). In
the same category, three inhibitory NK cell receptors
(NKRs): CD244 (natural killer receptor 2B4), CD300a, and
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Fig. 4 (See legend on next page.)
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KLRF1 (killer cell lectin-like receptor subfamily F, member
1) were all uniquely down-regulated, confirming the acti-
vated state of the stimulated NK cells. The cytokine IL-3
was uniquely up-regulated, which may suggest a unique
mechanism by which activated NK cells promote the de-
velopment and proliferation of other hematopoietic cells.
The cell surface signal transduction and cell adhesion
molecules CADM1 (cell adhesion molecule 1), SPTBN1
(spectrin, beta, non-erythrocytic 1), ITM2A (integral
membrane protein 2A) and P2RY10 (purinergic receptor
P2Y, G-protein coupled, 10) were uniquely down-
regulated, and CD38 and RGS16 (regulator of G-protein
signaling 16) were uniquely up-regulated (Fig. 4c). In the
category cell cycle and DNA replication, uniquely down-
regulated genes included CCNG2 (cyclin G2), ZFP36L2
(zinc finger protein 36, C3H type-like 2), SEPT6 (septin 6).
In the same category CCND2 (cyclin D2), CKS2 (CDC28
protein kinase regulatory subunit 2) were uniquely up-
regulated (Fig. 4d). Fig. 4e shows the expression profiles of
select genes within the transcription and translation cat-
egory. The uniquely down-regulated genes included sev-
eral DNA binding proteins, e.g., GATA3 (GATA binding
protein 3), CITED2 (Cbp/p300-interacting transactivator,
with terminal domain, 2) and HPIP (hematopoietic PBX-
interacting protein). The uniquely up-regulated genes
included BATF (basic leucine zipper transcription factor)
and several translation initiation factors (e.g., EIF1A,
EIF4A1, and EIF5a).
Real-Time PCR verified the predicted changes in ex-
pression of representative genes in response to NK cell
co-stimulation via immobilized IgG and IL-12 within
enriched functional categories (Fig. 4f ). Granzyme B
may be released in cytoplasmic granules from cytotoxic
T cells and NK cells to induce apoptosis of target cells,
and RT-PCR confirmed that this gene is up-regulated
following co-stimulation of NK cells (Figs. 4a and f). In
the cytokine and growth factor category, CXCR4 down-
regulation was also validated by Real-Time PCR (Figs. 4b
and f). CXCR4 has been reported to be expressed on
NK cells and is involved in the migration of NK cells in
response to CXCR4 ligand [40]. In the category cell
surface signal transduction, the gene CD38 was up-
regulated approximately 4-fold (Figs. 4c and f). CD38
has been shown to associate with the FcR to activate
signal transduction pathways, which includes calcium
fluxes, tyrosine phosphorylation of ZAP70 and mitogen-
activated protein kinase, and secretion of IFN-γ and GM-
CSF [41, 42]. Cyclin D2, which belongs to the cell cycle/
DNA replication category, was confirmed to be up-
regulated 3-fold (Figs. 4d and f). In the category transcrip-
tion and translation, BATF was found to be up-regulated
2.8-fold (Figs. 4e and f). In addition to Real-Time PCR ana-
lyses, we further incorporated bioinformatics-based ap-
proaches to gain insight regarding the mechanism of NK
cell activation following FcR stimulation in the presence or
absence of IL-12.
Leveraging network-centric measures to discover novel
genes
It is recognized that significant alterations in individual
gene expression may not comprehensively reflect the
biological response of NK cells to FcR and IL-12R stimu-
lation. Thus, we constructed a functionally enriched, in-
tegrated network connecting the differentially expressed
genes identified in this study with other genes in the
same or similar functional categories via GeneMANIA
in order to: i) elucidate the biological context of gene
expression changes of immobilized IgG and IL-12 stimu-
lated NK cells and ii) identify additional key genes that
might be involved in NK cell activation. A subset of this
network including the most highly connected genes is
shown in Additional file 4. Table 1 lists the top twenty
genes in the network ranked according to their between-
ness centrality (BC) measures. BC is an indicator of the
primary “bridges” between functionally segregated clus-
ters within a gene network (see Methods). This specific
relative ranking was selected as one of the criteria to
analyze the network since gene-to-gene functional link-
ages were found to be mostly unidirectional. That is, if a
gene influenced another gene via a given functional link-
age, then the influenced gene would rarely reciprocate
along the same functional linkage. The centrality of a
node reveals its connectivity with other nodes, or genes,
in an integrated network. Of note, the IL-21 receptor,
IL21R, was found to exhibit the highest BC score in the
integrated network. This indicates that the IL-21 recep-
tor serves as a critical link between other important
genes and relationships within the activated NK cell
(See figure on previous page.)
Fig. 4 Genes uniquely regulated in NK cells following FcR activation in the presence of IL-12 grouped by function. Gene expression values of genes
differentially expressed by at least 2-fold by NK cells stimulated by immobilized IgG plus IL-12 vs. those stimulated by Medium. Bars represent fold
change of the mRNA level of a particular gene when comparing the subpopulations. Positive values indicate that the transcript was more abundant in
the stimulated cells and negative values indicate that the gene was down-regulated in the stimulated cells. Genes were grouped according to their
presumed function (a-e) based on information available in public databases or in the literature (see Materials and Methods). f Validation of microarray
gene expression estimates by Real-Time PCR. Shown is fold change in gene expression (vs. no stimulation) within NK cells following FcR activation
(IgG), IL-12 stimulation (IL-12), or FcR activation in the presence of IL-12 (IgG plus IL-12). Representative data from a single donor out of three examined
is shown for each gene listed on the right
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gene network. Importantly, 6 out of the 20 highly ranked
BC genes (CCR5, CXCR6, IL2RB, IRF1, STAT4 and
TBX21) were not recovered in our filtering criteria to
identify differentially expressed genes in the original
microarray experiments and were exclusively identified
via mapping functional linkages as described in the
Methods section.
In order to illustrate a deeper level of network con-
nectivity analysis beyond betweenness centrality, includ-
ing connection cardinality, we further analyzed genes in
the network according to authority and hub metrics.
Table 2a classifies the highest ranked genes according to
their authority measures (n = 9), while Table 2b includes
a set of genes ranked according to their hub measures
(n = 9). Using the HITS algorithm, a node achieves a
high authority measure when several important nodes
within the integrated network point to it. In this study, a
high authority measure indicates a gene that is a suitable
indicator of the functional patterns in its neighborhood
within the gene network. In contrast, a high hub meas-
ure is an indicator of the direct connections a node
makes with other nodes in the integrated network. If a
node with a high hub measure is removed from the
network, the entire network will be disrupted, and previ-
ously connected sub-networks will fragment into uncon-
nected gene clusters. In order to obtain numerical
scores, authority nodes are quantified via summing the
hub nodes that are directed towards them, and hub
nodes are quantified via summing the authority nodes
that it are directed towards them. NLRP1 was the high-
est ranked authority gene, followed by BIRC3 and
EIF4A1. In regards to important hub genes, CASP1 was
found to be the most important followed by FASLG and
TRAF1. Of note, all of the authority genes were identi-
fied in the original microarray differential expression
analyses. Interestingly, nearly 45 % (4 out of 9) hub
genes were exclusively recovered via computational
means and mapping functional linkages. These four
genes include NFKBIA, PTPRC, TNFRSF1B and the top-
ranked hub gene, CASP1. Further, no individual gene was
identified as a combined highly ranked BC, authority, and
hub gene. Only 1 out of the 9 hub and 9 authority genes
Table 1 List of most highly ranked genes based on Betweenness
Centrality (BC) score





















BC scores were calculated via the PAJEK algorithm (22), and are presented in
decreasing order within the integrated network. A higher BC score indicates
that a given gene is highly interconnected with other genes and
gene products
























The HITS algorithm was used to measure two important characteristics of an
overall genomic network: the authority of individual genes, which may be
interpreted as a surrogate marker for the relative “importance” of those genes
to the overall function of the network (Table 2a); and the hub value of
individual genes, which is a surrogate marker for the relative “impact” of that
gene on the interconnections or relationships between genes that make up
that same network (Table 2b). Authority and Hub scores are presented in
decreasing order within the integrated network
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was found to be common between the two groups: namely
FAS. Similarly, only FASLG was identified as both a hub
and BC gene. A slightly higher proportion of authority
genes (3/9) were found to be BC genes, and vice versa (3/
20 BC genes): EIF4A1, TNFRSF9, and IFNG.
Discovering the highest represented pathways
We next used Ingenuity Pathway Analysis (IPA) to illus-
trate the most common canonical pathways associated
with the genes that were differentially expressed (2-fold or
greater regulation) in NK cells stimulated by immobilized
IgG plus IL-12 as well as those contained in the enriched
integrated network for this stimulation condition. The top
two IPA pathway networks are shown in Fig. 5. The top
two networks were chosen so that the resultant integrated
network was not too dense to be visualized as a two-
dimensional image. Table 3 lists constituent genes of the
top two pathways, where the differentially expressed genes
identified in the original microarray analysis are highly
represented. Future functional studies of the key genes
regulating NK cell signaling pathways identified in these
analyses may unveil previously unknown drivers of NK
cell function in the setting of monoclonal antibody ther-
apy for cancer.
Together, results derived from both canonical pathway
and topological network analyses provide insight into
the diverse, interwoven network of genes involved in NK
cell activation. The systems-level observations generated
in this study may serve as a basis for identification of
important candidate genes to be investigated in future
functional studies and subsequently, serve as targets for
diagnostic or therapeutic interventions.
Discussion
The major goal of this study was to gain insight into the
function of NK cells upon encounters with Ab-coated
Fig. 5 An integrated visualization of the top two networks generated by IPA. The connections between genes in the NK cell signaling pathways
have been highlighted using blue edges. Red nodes represent up-regulated genes, and green nodes represent down-regulated genes identified
in our differential expression analysis (based on NK cells dual-stimulated via IgG and IL-12). The darker the node color, the more extreme (high or
low) the up- or down-regulation of the respective gene. White nodes represent genes that were not originally identified in our microarray analysis
but are connected to other genes within the enriched network. Blue nodes represent genes from canonical pathways. Relationship types are outlined
in the figure legend
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targets in the presence of locally secreted cytokines from
both an immunological and bioinformatics-based per-
spective. In the present study, we utilized oligonucleo-
tide microarrays to evaluate the gene expression profile
of NK cells following FcR activation in the presence of
the powerful pro-inflammatory cytokine, IL-12. We fur-
ther employed several systems-level analyses, including
functional enrichment as well as network centrality and
pathway analysis, in order to determine key genes and
biological functions influencing the responses of NK
cells encountering Ab-coated target cells in an inflam-
matory environment. The most common biomolecular
functions identified amongst the differentially expressed
genes were utilized to aggregate additional genes with
the same or similar cellular, molecular, or biological
functionality into an integrated network. Furthermore,
network analysis metrics, including betweenness central-
ity, authority, and hub measures were employed to rank
the relative importance of genes in the overall integrated
network. To our knowledge, this is the first application
of sophisticated network-level analyses to describe the
genetic profile of a clinically relevant population of acti-
vated NK cells. We report herein the gene expression
profile induced within FcR and cytokine stimulated NK
cells and highlight potential key regulators of NK cell ac-
tivity in inflammatory settings.
Several unique genes in the combined immobilized
IgG plus IL-12 stimulation condition exhibited signifi-
cance in both the microarray data set as well as the
enriched gene network generated in the bioinformatics-
driven portion of this study. Select members of the
Tumor Necrosis Factor Receptor Superfamily (TNFRSF)
were found to be significantly up-regulated in the micro-
array gene expression studies and were identified as key
entities in the overall enriched network (TNFRSF4: BC
Rank 5, TNFRSF9: BC Rank 11 and Authority Rank 6,
and TNFRSF1B: Hub Rank 6). Accordingly, TNF-α in-
duction in immobilized IgG plus IL-12 activated NK
cells was confirmed via enzyme-linked immunosorbent
assays (ELISA) as well as RT-PCR studies. Moreover, the
Basic leucine zipper transcription factor, ATF-like (BATF,
BC Rank 10) was the most highly up-regulated gene in
the Transcription/Translation category of the microarray
studies. This gene has been shown to interact with Inter-
feron Regulatory Factor 4 (IRF4, BC Rank 3 in the
enriched network generated in this study) to promote
transcriptional activation in T cells, support develop-
ment of dendritic cells, and to aid in the immune re-
sponse against invading pathogens [43, 44]. The results
in this study may indicate a potential role for BATF and
IRF4 interactions in the NK cell response to immune-
based therapies. Also, recent studies have examined the
role of the Aryl Hydrocarbon Receptor (AHR) in NK cell
development [45]. It has been suggested that AHR influ-
ences the expression of the transcription factor T-Box
Protein 21 (TBX21) and has downstream effects on NK
cell IFN-γ production. In this study, IFN-γ production
was significantly increased in FcR and IL-12R activated
NK cells, and this gene exhibited a BC Rank 13 and
Authority Rank 9 in the enriched gene network. More-
over, AHR expression was up-regulated 2-fold in the
microarray data set, and TBX21 exhibited a BC Rank 12
in the enriched gene network. The importance of AHR,
TBX21, and IFNG were highlighted in both laboratory-
and bioinformatics-based portions of this study, support-
ing further investigation into their interactions and
potential role in the function of activated NK cells. In
summary, these findings indicate that genes identified
using genome-wide profiling and those that were priori-
tized via computational functional enrichment and path-
way analyses may serve as interesting targets for future
studies to better understand the mechanisms underlying
NK cell activation.
Interestingly, bioinformatics-based analyses revealed
that the IL21R exhibited the highest BC score within
the activated NK cell gene network, indicating its im-
portance within the genetic framework governing NK
cell anti-tumor activity. In the laboratory-based studies,
evaluation of IL21R expression by Real-Time PCR
revealed an intriguing differential regulation that may
Table 3 Top two networks along with their constituent genes and associated canonical scores as calculated by IPA.
ID Molecules in the Network IPA
Score
Top Functions
1 ADRB2, BCL11B, BHLHEA40, BTG3, CD38, COLQ, CSF2, DUSP5, EGR2, EGR3, Fcgr2,
FCGR3A, FGR, HLA-DQ, HSPE1, IARS, IER3, Ifn gamma, IL21R, KDM68, lymphotoxin-
alpha1-beta2, MTHFD2, MXI1, NINJ1, Nr1h, NR4A2, NR4A3, PDGF BB, Pka, PRSS23,
PTGDR, RGS2 (includes EG:19735), SDC4, SLC7A1, TNF
37 Connective Tissue Disorders, Immunological
Disease, Inflammatory Disease
2 AHR, BCL2A1, BCR (complex), CCL1, CD226, CD244, CFLAR, CXCL9, CXCL11, Fcer1,
FCGR3B, GTPBP4, Igm, IL10RA, IL15RA, Immunoglobulin, ITGAL, KLF2, Lfa-1, NFkB
(complex), NLRP1, NOP14, PI3K (family), PLCG2 (includes EG:234779), PYCARD,
RRAS2, TFRC, TICAM1, TNFAIP8, TNFRSF4, TNFRSF9, TNFSF11, TRAF1, TSC22D3,
ZAP70
37 Cellular Development, Cellular Growth and
Proliferation, Hematological System Development
and Function
The gene names in bold text indicate those genes that were included in the original microarray data set for NK cells stimulated via IgG and IL-12. The assertion
“top two” indicates that the maximal number of genes from the integrated network belonged to these two pathways according to the IPA analysis tool
Campbell et al. BMC Medical Genomics  (2015) 8:66 Page 13 of 17
explain the mechanisms utilized by NK cells upon en-
counters with Ab-coated targets in different environments.
For example, expression of the IL21R was significantly en-
hanced in response to FcR activation alone, but neither
enhanced nor inhibited in response to FcR activation in
the presence of IL-12. Previous reports have shown that
IL-21 enhances CD56dimCD16+ NK cell cytotoxicity and
cytokine production in response to Ab-coated targets
[46, 47]. Hence, up-regulation of the IL21R upon en-
counters with Ab-coated targets alone may reflect an
endogenous mechanism that allows for rapid enhance-
ment of NK cell activity responsible for further inflamma-
tion and recruitment of the adaptive immune response.
As a key player within the integrated gene network, add-
itional investigation is essential in order to better under-
stand the complex role of IL-21 and its receptor on NK
cell anti-tumor activity.
Further, given that immune cell crosstalk plays a crit-
ical role in the anti-tumor immune response, we were
interested in the regulation of genes that may facilitate
cellular interactions between activated NK cells and
other immune cells within the tumor microenvironment.
In particular, myeloid-derived suppressor cells (MDSCs)
increasingly have been recognized as major players in
suppression of the anti-tumor immune response. While
several manuscripts have highlighted the importance of
interactions between T cells and MDSCs, less is known
about the relationship between NK cells and MDSCs [48,
49]. The current study provides several interesting obser-
vations suggesting the potential for crosstalk between acti-
vated NK cells and MDSCs. Following stimulation of the
FcR and IL-12R, NK cell expression of the IL-10 receptor
(IL10RA) was significantly down-regulated according to
the microarray and bioinformatics-based analyses. This is
of interest, as several reports have shown that MDSCs
produce IL-10, and IL-10 also has been shown to promote
NK cell proliferation and cytotoxic activity against tumor
cells [50–53]. In addition, dual stimulated NK cells
exhibited increased expression of CSF2 (also known as
GM-CSF) and TNF. Both of these cytokines have been
demonstrated to drive the accumulation and suppressive
function of MDSCs in multiple tumor models [54, 55].
TNFRSF9 was shown to be an important player in both
the microarray data set and in various bioinformatics-
based analyses as well. TNFRSF9 associates with 41BB to
form CD137, a T cell and NK cell co-stimulatory mol-
ecule. Signaling via CD137 has been shown to suppress
CD4+ T cell activation, stimulate CD8+ T cell activity and
increase proliferation of CD11b+Gr-1+ myeloid derived
suppressor cells (MDSCs) [56]. Notably, recent studies
have demonstrated increased CD137 expression on NK
cells following interactions with mAb-coated tumor
cells [57]. NK cell anti-tumor activity therefore may be
enhanced via combination therapy including a tumor
antigen-specific mAb and an agonistic anti-CD137 mAb.
In addition, it may be important to examine the impact of
anti-CD137 mAb therapy on inhibitory MDSC in future
studies. Lastly, we observed an increase in CCL1 expres-
sion in dual stimulated NK cells. Studies have shown that
MDSCs from patients with urothelial and renal cell car-
cinoma express CCR8 (the CCL1 receptor), and tumor-
derived CCL1 promotes the accumulation of MDSCs in
both the peripheral blood and tumor tissue [58]. While
identifying potential interactions between NK cells and
MDSCs was not the primary objective of this study, our
observations suggest that further investigation to better
understand NK cell and MDSC crosstalk will yield inform-
ative results regarding the immune response to monoclo-
nal antibody therapy for cancer.
Network-based approaches have been successfully ap-
plied in a variety of immune cell contexts. In a recent
study comparing the transcriptional responses of NK cells
activated via P. falciparum laboratory strain 3D7 and NK
cells treated with IL-12 and IL-18, the authors used
microarray and networks analysis to identify distinct genes
and pathways involved in these responses including
TREM1 signaling and protein ubiquitination processes
[59]. In another study analyzing gene expression signa-
tures using Ingenuity database information and Bayesian
inference in the context of T cell activation, Jagged1 was
shown to modulate T cell activation in PBMCs from
multiple sclerosis patients [60]. The authors further
showed that a Jagged1 agonist ameliorated the disease
course in a mouse model of autoimmune encephalomy-
elitis. Additional applied immunoinformatics frame-
works include the statistically powerful weighted gene
co-expression network analysis (WGCNA), whereby
novel biological modules and pathways may be discov-
ered [61], as well as ontology-based methods to define
novel biomarkers and infer biological functions [62].
Our immunological evaluation of activated NK cells
could be limited in the current study because only one
type of co-stimulation condition, immobilized IgG and IL-
12, was examined. Of note, as shown in Fig. 3a, NK cell
IFN-γ production was greater in response to co-culture
with trastuzumab-coated cells and IL-12 compared to that
of immobilized IgG and IL-12 stimulated cells. This find-
ing could indicate that a potentially different stimulatory
environment may be encountered by NK cells interacting
with Ab-coated tumor cells as compared to those that
engage only immobilized IgG. Further, incorporating mul-
tiple NK cell stimulation strategies may more effectively
represent the complex relationships among other cyto-
kines and NK cell activity. For instance, Smith et al. per-
formed a small-scale study of global gene expression
changes in NK cells co-stimulated by IL-2, IL-12, and IL-
18 compared to unstimulated NK cells [63]. Like our
study, the authors found that several effector cytokines,
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including IFNG as well as various TNF family members,
were transcriptionally up-regulated in response to co-
stimulation. Of the top 150 genes differentially expressed
in the Smith et al. study, nearly 10 % were sequence-
specific DNA-binding transcription factors, which is con-
sistent with the central role of nuclear transcription factor
responses in activated NK cells demonstrated in this
study. Though our in vitro validation of microarray gene
expression estimates by Real-Time PCR was somewhat
limited in scope, future studies will include additional
functional analyses of high-yield gene targets based on this
initial genome-wide investigation. Also, utilizing heuristic-
ally defined thresholds (>2-fold changes in gene expres-
sion) to define significance may have limited our ability to
recover genes that were more subtly expressed individu-
ally, but in combination with other genes, may represent
important regulators of NK cell activation. Further inter-
rogation of co-expression modules and integration of add-
itional canonical knowledge and experimental evidence
will advance our current findings. An important re-
source for future integrative genomics studies is The
Immunological Genome Project (ImmGen) database of
murine-derived gene expression and regulatory net-
works of all immune cells [64]. For example, Xue et al.
conducted transcriptome and network-based analyses
of human macrophage activation and subsequently in-
tegrated their data with core signatures of dendritic
cells and macrophages contained within ImmGen. In
doing so, they were able to classify several conserved
genes involved in regulation of macrophage activation
[65]. A preliminary analysis of ImmGen NK cell whole-
genome microarray data sets demonstrated a unique
transcriptional relationship between resting NK cells
and T cells and may serve as a valuable resource for fu-
ture studies investigating the global molecular aspects
underlying NK cell function [66].
Conclusions
This study has combined bioinformatics-driven network
analyses with immunological laboratory-based studies to
identify important genes modulating NK cell function fol-
lowing physiologically relevant activation. By utilizing an
integrated approach that brings together multiple network-
level analyses, we have created a compendium of important
genes and pathways for future study. The results presented
herein highlight the involvement of a number of genes
simultaneously regulated within NK cells following cyto-
kine and FcR activation and suggest unique mechanisms
by which CD56dimCD16+ NK cells respond to Ab-coated
targets under pro-inflammatory conditions. It is our hope
that this study may serve as the first step towards a
powerful mechanism for evaluating genetic functionality
in the context of a multi-dimensional, multi-disciplinary
approach to understanding NK cell function.
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Additional file 1: Supplemental Table 1 provides a full list of
differentially expressed (2-fold or greater) genes from the
microarray studies and their change in expression calculated from
the following comparisons: 1) immobilized IgG stimulated NK cells
vs. unstimulated NK cells (medium), 2) IL-12 stimulated NK cells vs.
medium, and 3) IgG plus IL-12 co-stimulated NK cells vs. medium.
(XLS 125 kb)
Additional file 2: 2a and 2b are entitled Functional analysis of the
genes regulated in NK cells following FcR activation, IL-12 stimulation
or the combination reveals distinct functional grouping in each gene
list (DAVID). These figures represent the functional characteristics of up-
(2a) or down-regulated (2b) genes from available gene ontology (GO)
annotations in public databases. (PPT 159 kb)
Additional file 3: Supplemental Table 2 contains a complete list of
the individual genes within each functional category. (XLS 45 kb)
Additional file 4: A sub-network among 33 unique genes repre-
senting the hub, authority and high BC ranked vertices from the
overall integrated network. (PPT 407 kb)
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